Persistent and progressive pulmonary fibrotic changes in a model of fat embolism

Journal of Trauma and Acute Care Surgery

Volumn 72, Issue 4, 2012, Pages 992-998

  Poisner, Alan M ^a   Adler, Federico ^a   Uhal, Bruce ^c   McIff, Terence E ^a   Schroeppel, John P ^a   Mehrer, Aaron ^b   Herndon, Betty L ^b   Lankachandra, Kamani M ^b   Molteni, Agostino ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Angiotensin peptides; Fat embolism; Orthopedic procedures; Pulmonary injury; Trauma

Indexed keywords

ANGIOTENSIN; COLLAGEN; FAT; FAT DROPLET; SMOOTH MUSCLE ACTIN; SODIUM CHLORIDE; TRIOLEIN; ANGIOTENSIN DERIVATIVE;

ADVENTITIA; AIRWAY; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; EOSINOPHIL; ERYTHROCYTE; EUTHANASIA; FAT EMBOLISM; HISTOPATHOLOGY; INFERIOR CAVA VEIN; INFLAMMATION; INFLAMMATORY CELL; LIVER; LUNG ALVEOLUS; LUNG FIBROSIS; LUNG INJURY; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; SPLEEN; VASCULITIS; WEIGHT GAIN; ANIMAL; CHEMISTRY; DISEASE COURSE; DISEASE MODEL; LUNG; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSINS; ANIMALS; COLLAGEN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EMBOLISM, FAT; FATS; LUNG; MALE; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84862742011     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31823c96b0     Document Type: Article

References (20)

1. Roberts CS, Gleis GE, Seligson D. Diagnosis and treatment of complications. In: Browner BD, Jupiter JB, Levine AM, Tafton PG, Krettek C, editors: Skeletal Trauma. 4th ed. Philadelphia, PA: WB Saunders; 2009:515-588.
2. Akhtar S. Fat embolism. Anesthesiol Clin. 2009;27:533-550.
3. Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364: 1293-1304.
4. King EG, Wagner WW, Jr., Ashbaugh DG, Latham LP, Halsey DR. Alterations in pulmonary microanatomy after fat embolism. In vivo observations via thoracic window of the oleic acid-embolized canine lung. Chest. 1971;59:524-530.
5. Liu DD, Hsieh NK, Chen HI. Histopathological and biochemical changes following fat embolism with administration of corn oil micelles: a new animal model for fat embolism syndrome. J Bone Joint Surg Br. 2008;90:1517-1521.
6. Jacobovitz-Derks D, Derks CM. Pulmonary neutral fat embolism in dogs. Am J Pathol. 1979;95:29-42.
7. McIff TE, Poisner AM, Herndon B, et al. Fat embolism: evolution of histopathological changes in the rat lung. J Orthop Res. 2010;28:191-197.
8. Molteni A, Poisner AM, McIff TE, et al. Progressive pulmonary fibrotic changes in a model of fat embolism in the rat. Presented at 16th International Colloquium on Lung and Airway Fibrosis, Busselton, Australia; 2010:44.
9. Junqueira M, Adler F, Poisner A, et al. Long term effects of fat on the pulmonary Clara cells in a fat embolism rat model. Presented at 16th International Colloquium on Lung and Airway Fibrosis, Busselton, Australia; 2010:42.
10. Uhal B, Poisner AM, Adler F, et al. Evidence that local expression of angiotensin peptides mediates lung fibrosis after experimental fat embolism induced by injection of triolein in rats. Presented at 16th International Colloquium on Lung and Airway Fibrosis, Busselton, Australia; 2010:47.
11. Inoue H, Hanagama M, Kamiya M, Shinone K, Nata M. Experimental pulmonary fat embolism induced by injection of triolein in rats. Leg Med. 2008;10:26-30.
12. Molteni A, Wolfe LF, Ward WF, et al. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-Beta) and alpha actomyosin (Alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. Curr Pharm Des. 2007;13:1307-1316.
13. Li X, Molina-Molina M, Abdul-Hafez A, et al. Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2006;291:L887-L895.
14. Cohen EP, Molteni A, Hill P, et al. Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab Invest. 1996; 75:349-360.
15. Molteni A, Moulder JE, Cohen EP, et al. Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker. Exp Biol Med (Maywood). 2001;226: 1016-1023.
16. Marshall RP, Bellingnan G, Webb S. et al. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Resp Crit Care Med. 2000;162:1783-1788.
17. Wilcox ME, Herridge MS. Long-term outcomes in patients surviving acute respiratory distress syndrome. Sem Resp Crit Care Med. 2010;31: 55-65.
18. McIff TE, Poisner AM, Herndon B, Lankachandra K, Molteni A, Adler F. Mitigating effects of captopril and losartan on lung histopathology in a rat model of fat embolism. J Trauma. 2011;70:1186-1191.
19. Chao J, Wood JG, Blanco VG, Gonzalez NC. The systemic inflammation of alveolar hypoxia is initiated by an alveolar macrophage-borne mediator(s). Am J. Respir Cell Mol Biol. 2009;41:573-582.
20. Gonzalez NC, Wood JG. Alveolar hypoxia-induced systemic inflammation: what low PO(2) does and does not do. Adv Exp Med Biol. 2010;662:27-32.